Back to Janus Henderson Group Ltd.

BBIO
Showing 8 of 22 quarters

Position history for Janus Henderson Group Ltd.'s holdings in BRIDGEBIO PHARMA INC

Janus Henderson Group Ltd. holds 13.2M shares of BBIO (BRIDGEBIO PHARMA INC), worth $978.6M as of 2026-Q1. The position was increased (+19.8% shares). BBIO represents 0.5% of Janus Henderson Group Ltd.'s portfolio.

Current Value

$978.6M

Current Shares

13.2M

Total Value Change

+$869.3M

Total Shares Change

+8.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
13.2M
+19.8%
$978.6M0.5%$64.53
45
2025-Q4
Increased
11M
+25.9%
$841.3M0.4%$75.48
47
2025-Q3
Decreased
8.7M
-5.8%
$454M0.2%$51.96
0
2025-Q2
Increased
9.3M
+29.4%
$400.5M0.2%$44.86
47
2025-Q1
Increased
7.2M
+46.1%
$251.7M0.1%$35.11
50
2024-Q4
Increased
4.9M
+1.9%
$134.7M0.1%$27.32
31
2024-Q3
Increased
4.8M
+11.7%
$122.7M0.1%$24.94
34
2024-Q2
Increased
4.3M
+30.2%
$109.3M0.1%$25.33
38

Other major holders of BBIO: VIKING GLOBAL INVESTORS LP, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used